Circulating Tumour Cell Biomarkers in Head and Neck Cancer: Current Progress and Future Prospects

Head and neck cancer (HNC) continues to carry a significant burden of disease both for patients and health services. Facilitating biomarker-led treatment decisions is critical to improve outcomes in this group and deliver therapy tailored to the individual tumour biological profile. One solution to...

Descripción completa

Detalles Bibliográficos
Autores principales: Payne, Karl, Brooks, Jill, Spruce, Rachel, Batis, Nikolaos, Taylor, Graham, Nankivell, Paul, Mehanna, Hisham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721520/
https://www.ncbi.nlm.nih.gov/pubmed/31387228
http://dx.doi.org/10.3390/cancers11081115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721520/
https://www.ncbi.nlm.nih.gov/pubmed/31387228
http://dx.doi.org/10.3390/cancers11081115

Ejemplares similares